Go to Page # Page of 4
loading

ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes

 GlaxoSmithKline
  24th-Jul-2008
Views: 1767
Domain: Medical
Category: Biotech/Pharma
Contents:
GlaxoSmithKline responds to JAMA article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes 11 December 2007 -- The following is GlaxoSmithKline's [NYSE: GSK] response to the retrospective analysis by the Institute for Clinical Evaluative Sciences (ICES) titled "Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes". GSK believes tha ... See more

Recent Presentations

What is Trust Have To Do With Compassion?

Trends of trust in healthcare. Trust needed for conversation between patients & physicians on overuse. Trust should be a core operating principle in health care.

...
21 August, 2019
...
20 August, 2019
Yalin Firinci
19 August, 2019